GPT and acneiform dermatitis: Common TRAE: dermatitis acneiform, dry skin, nausea, and stomatitisG3-4 TRAE: 43% (most commonly dermatologic)TRAE to d/c regimen: 2% for sotorasib (ALT increased), 4% for panitumumab and 24% for FOLFIRI